Citations

Clear

17 citation(s) found for "Shah, Samir".

Dysplasia detection using high-definition scopes with dye vs virtual chromoendoscopy in IBD: A meta-analysis of randomized clinical trials
Mohamed, Mouhand F. H., Chu, Jacqueline J. , Beran, Azizullah, Ahmed, Khalid , Shah, Samir , Nayfeh, Tarek

Mayo Clinic

Inflammatory Bowel Diseases | January 23, 2026 | Volume: 32 | Issue: 7 | Pages: 1410-1414

10.1093/ibd/izag019 | PMID 41701117 Get It

Lay Summary This meta-analysis of 8 randomized controlled trials compares the effectiveness of using high-definition scopes with virtual chromoendoscopy vs dye chromoendoscopy for detecting dysplasia in inflammatory bowel disease patients. Overall, the odds of dysplasia detection were not significantly different between dye chromoendoscopy and virtual chromoendoscopy.
Medical management of inflammatory bowel diseases
Limdi, Jimmy K. , Shapiro, Jason M. , Shah, Samir A. , Hashash, Jana G.

Mayo Clinic

BMJ | December 19, 2025 | Volume: 391 | Issue: No issue available | Pages: e079050

10.1136/bmj-2025-079050 | PMID 41419296 Get It

Abstract Inflammatory bowel diseases (IBD), comprising Crohn’s disease and ulcerative colitis, are chronic, inflammatory, immune mediated, relapsing-remitting conditions of the gastrointestinal tract with multidimensional and often negative effects on patients’ quality of life. The global burden of IBD is increasing and is forecast to affect 1% of the population in early industrialized nations over the next 10 years. Advances in our understanding of the causes and pathogenesis of IBD in the past three decades have translated into new treatments that modulate the immune inflammatory cascade. Modern goals of treatment are clinical remission through assessment of patient reported outcomes and deep remission defined as mucosal healing on colonoscopy or imaging. Achieving both clinical and deep remission affords patients a better long term prognosis and quality of life. This review summarizes the latest evidence on IBD diagnosis, staging, and prognosis, with a detailed focus on current treatments.
S1277 No Differences in Dysplasia Detection Between Dye and Virtual Chromoendoscopy Techniques: Results From a Meta-Analysis of Randomized Clinical Trials
Mohamed, Mouhand , Shah, Samir A. , Mohamed, Mouhand F H , Beran, Azizullah , Ahmed, Khalid

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S910-S911

10.14309/01.ajg.0001034476.12410.15 Get It

S1278 Polypharmacy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
Mohamed, Mouhand , Kwon, Michelle, Shah, Samir A. , Mohamed, Mouhand F H , Beran, Azizullah , Elfert, Khaled

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S911-S912

10.14309/01.ajg.0001034480.76266.fb Get It

Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE
Fiske, Hannah W. , Shah, Samir A. , Al-Bawardy, Badr , Binion, David G. , Bohm, Matthew , Brand, Myron, Cohen, Benjamin L, Dueker, Jeffrey, Engels, Michael , Fine, Sean , Förster, E , Gaidos, Jill , Ginsburg, Philip, Goyal, Alka , Hanson, John S. , Herfath, Hans, Hull, Tracy L. , Kelly, Colleen , Lazarev, Mark , Levy, L. Campbell, Melia, Joanna , Philpott, Jessica, Qazi, Taha , Watson, Andrew , Wexner, Steven D. , Williams, Emmanuelle, Al‐Bawardy, Badr , Al-Bawardy, Badr , Bohm, Matthew , Fine, Sean , Forster, Erin , Gaidos, Jill K J , Hull, Tracy , Melia, Joanna , Qazi, Taha , Regueiro, Miguel , Wexner, Steven D , Ward, Chris , Holubar, Stefan D. , Barnes, Edward L. , Clarke, Kofi , Cohen, Benjamin L, Cross, Raymond K. , Farraye, Francis A. , Hanson, John, Philpott, Jessica R., Siegel, Corey A , Regueiro, Miguel

Mayo Clinic

Crohn's & Colitis 360 | April 10, 2024 | Volume: 6 | Issue: 2 | Pages: No page available

10.1093/crocol/otae022 | PMID 38720935 Get It

Abstract Background Since 2009, inflammatory bowel disease (IBD) specialists have utilized “IBD LIVE,” a weekly live video conference with a global audience, to discuss the multidisciplinary management of their most challenging cases. While most cases presented were confirmed IBD, a substantial number were diseases that mimic IBD. We have categorized all IBD LIVE cases and identified “IBD-mimics” with consequent clinical management implications. Methods Cases have been recorded/archived since May 2018; we reviewed all 371 cases from May 2018–February 2023. IBD-mimics were analyzed/categorized according to their diagnostic and therapeutic workup. Results Confirmed IBD cases made up 82.5% (306/371; 193 Crohn’s disease, 107 ulcerative colitis, and 6 IBD-unclassified). Sixty-five (17.5%) cases were found to be mimics, most commonly medication-induced (n = 8) or vasculitis (n = 7). The evaluations that ultimately resulted in correct diagnosis included additional endoscopic biopsies (n = 13, 21%), surgical exploration/pathology (n = 10, 16.5%), biopsies from outside the GI tract (n = 10, 16.5%), genetic/laboratory testing (n = 8, 13%), extensive review of patient history (n = 8, 13%), imaging (n = 5, 8%), balloon enteroscopy (n = 5, 8%), and capsule endoscopy (n = 2, 3%). Twenty-five patients (25/65, 38%) were treated with biologics for presumed IBD, 5 of whom subsequently experienced adverse events requiring discontinuation of the biologic. Many patients were prescribed steroids, azathioprine, mercaptopurine, or methotrexate, and 3 were trialed on tofacitinib. Conclusions The diverse presentation of IBD and IBD-mimics necessitates periodic consideration of the differential diagnosis, and reassessment of treatment in presumed IBD patients without appropriate clinical response. The substantial differences and often conflicting treatment approaches to IBD versus IBD-mimics directly impact the quality and cost of patient care.
Abstract 17939: Predictors of Time in Target Range in a Comprehensive Self-Measured Blood Pressure Program in a Socially and Economically Disadvantaged Primary Care Population
Shah, Samir , Hartley, M, Rodriguez, Jordan, Martinez, Omar Cantu, Suarez, Audry Chacin, Behme, Matthew, Copeland, Joshua A, Chacin‐Suarez, Audry

Mayo Clinic

Circulation | December 19, 2023 | Volume: 148 | Issue: Suppl_1 | Pages: No page available

10.1161/circ.148.suppl_1.17939 Get It

Introduction: The Community Practice Center (CPC) in North Philadelphia serves a community with significant socioeconomic barriers leading to inability to access care necessary for management of hypertension (HTN). Prior studies have shown the efficacy of SMBP programs in improving blood pressure (BP) control. Methods: All sequential patients presenting to the CPC with stage 2 HTN were screened for eligibility. Upon enrollment, patients received a Bluetooth-enabled BP cuff connected to a mobile health app and HTN education. Patients completed validated social and behavioral assessments including social determinants of health (SD)H) assessment via WellRx screen, depression screening (PHQ-9), and self-efficacy screening ( Self-Efficacy to Manage Chronic Disease Scale ). A behavior change plan was created using Brief Problem Solving Therapy based on the aforementioned assessments. Staff continuously monitored usage, BP, and provided individualized interventions. We conducted a cross-sectional quality improvement study using daily BP data from June 2022 - April 2023 to assess the correlation between baseline sociodemographic characteristics and Time in Target Range (TTR) through multivariable linear regression. We calculated TTR, defined as the percentage of time with systolic BP within 100-130 mmHg, through linear interpolation. Results: A total of 133 patients were enrolled in the program. We analyzed data from 78 patients with ≥3 days of readings (average 33; SD 49) and complete baseline characteristics (Table 1). Female sex and non-smoking status were associated with TTR, while diabetes, positive depression screening, positive SDOH screening, and self-efficacy were not (Table 2). Conclusions: In a socioeconomically disadvantaged population participating in a comprehensive SMBP program, depression, SDOH, and self-efficacy screening at time of enrollment did not predict TTR. Participation in a SMBP program may be valuable in these populations.
Dye Chromoendoscopy Outperforms High-Definition White Light Endoscopy in Dysplasia Detection for Patients With Inflammatory Bowel Disease: An Updated Meta-Analysis of Randomized Controlled Trials
Mohamed, Mouhand , Marino, Daniel, Elfert, Khaled , Nayfeh, Tarek , Abdallah, Mohamed A., Sultan, Shahnaz , Shah, Samir A. , Mohamed, Mouhand F H , Nayfeh, Tarek , Shah, Samir A , Beran, Azizullah , Abdallah, Mohamed A.

Mayo Clinic

American Journal of Gastroenterology | December 1, 2023 | Volume: 119 | Issue: 4 | Pages: 719-726

10.14309/ajg.0000000000002595 | PMID 38038351 Get It

INTRODUCTION: Whether dye spray chromoendoscopy (DCE) adds value in surveillance colonoscopy with high-definition (HD) scopes remains controversial. This updated meta-analysis compares dysplasia detection using DCE and high-definition white light endoscopy (HD-WLE) in patients with inflammatory bowel disease (IBD) undergoing surveillance colonoscopy. METHODS: A comprehensive search was performed for randomized controlled trials (RCT) comparing HD-WLE and DCE in patients with IBD. The primary outcome was to compare the proportion of patients with at least 1 dysplastic lesion detected by DCE vs HD-WLE. Odds ratios (OR) and 95% confidence intervals (CI) were pooled using the random-effects model, with I 2 > 60% indicating substantial heterogeneity. The Grading of Recommendations, Assessment, Development, and Evaluation approach was used to assess the certainty of evidence (CoE). RESULTS: Six RCT involving 978 patients were analyzed (DCE = 479 vs HD-WLE = 499 patients). DCE detected significantly more patients with dysplasia than HD-WLE (18.8% vs 9.4%), OR 1.94 (95% CI 1.21–3.11, I 2 = 28%, P = 0.006, high CoE). This remained significant after excluding 2 RCT published as abstracts. A sensitivity analysis excluding a noninferiority RCT with a single experienced operator eliminated the results' heterogeneity, OR 2.46 (95% CI 1.56–3.90, I 2 = 0%). Although high-grade dysplasia detection was numerically higher in the DCE group (2.8% vs 1.1%), the difference was statistically insignificant, OR 2.21 (95% CI 0.64–7.62, I 2 = 0%, low CoE). DISCUSSION: Our updated meta-analysis supports DCE as a superior strategy in overall dysplasia detection in IBD, even with HD scopes. When expertise is available, DCE should be considered for surveillance colonoscopy in patients with high-risk IBD, with the acknowledgment that virtual chromoendoscopy shows equivalence in recent studies. Further multicenter trials with multiple endoscopists with varying expertise levels and longer-term outcome data showing a reduction in cancer or cancer-related death are needed.
Abstract P325: Early Insights From A Self-measured Blood Pressure Program In A Socially And Economically Disadvantaged Primary Care Population
Martinez, Omar Cantu, Hartley, M, Suarez, Audry Chacin, Shah, Samir , Rodriguez, Jordan, Behme, Matthew, Copeland, Joshua A, Chacin‐Suarez, Audry

Mayo Clinic

Hypertension | October 11, 2023 | Volume: 80 | Issue: Suppl_1 | Pages: No page available

10.1161/hyp.80.suppl_1.p325 Get It

Background: Meta-analyses have shown the success of SMBP in BP control. We aim to describe an SMBP QI program at our primary care clinic and assess its impact on BP. The Einstein CPC is a safety net practice that serves a socially and economically disadvantaged population facing many HTN management barriers. Methods: This program utilized a QI approach for BP control and patient-provider connection. Patient demographics, clinical features, and SDOH were assessed at baseline. Patients with uncontrolled HTN (SBP >140 mmHg) were asked to participate. To date, 111 patients enrolled. Patients were given a Bluetooth-enabled BP monitor connected to a mobile health app, HTN education, DASH diet recommendations, and orientation to SMBP protocols. Those reporting social needs or depression were referred to behavioral resources. Health staff continuously telemonitored patient usage, BP, and individualized interventions. We evaluated the difference in BP from baseline BP and estimated the change in time using a linear multilevel model with random intercept and random slope for each patient. We also calculated time in target range defined as time in SBP 100-130 and DBP 70-80 in mmHg. Results: Patient characteristics (Table 1). Those with at least 3 d of BP readings - 93% (103/111) were included in the BP analysis (Figure 1); mean follow-up 69±67 d and BP readings 42±52. Over 90 d, SBP, and DBP decreased by 11 (95% CI: 4-17) and 5 (95% CI: 3-8) mmHg, respectively. Conclusions: A QI-based SMBP program with robust telemonitoring and individualized interventions may effectively promote short-term adherence to remote BP monitoring and BP control in a socially and economically disadvantaged population.
Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference
Kow, Alfred Wei Chieh , Martin, Eléonora De , Soejima, Yuji , Watt, Kymberly D. , Xia, Qiang , Saraf, Neeraj, Kamel, Refaat, Srinvasan, Parthi, Elsabbagh, Ahmed M. , Pamecha, Vinayendra, Palaniappan, Kumar , Mas, Valeria R. , Tokat, Yaman , Asthana, Sonal , Cherukuru, Ramkiran , Egawa, Hiroto , Lerut, Jan , Bröering, Dieter C. , Berenguer, Marina , Cattral, Mark S. , Clavien, Pierre‐Alain , Chen, Chao‐Long , Shah, Samir , Zhu, Zhi‐Jun , Emond, Jean C. , Ascher, Nancy L. , Rela, Mohamed , Kim, Dong‐Sik , Ikegami, Toru , Group, On behalf of the ILTS-iLDLT-LTSI SFSS Working, Watt, Kymberly, Berenguer, Marina , Liu, Jiang , Patel, Madhukar S. , Reddy, Mettu Srinivas , Syn, Nicholas L. X. , Nasralla, David , McKenna, Greg J. , Palaniappan, Kumar , Asthana, Sonal , Rammohan, Ashwin , Bhangui, Prashant , Group, On behalf of the ILTS-iLDLT-LTSI SFSS Working

Mayo Clinic

Transplantation | September 26, 2023 | Volume: 107 | Issue: 10 | Pages: 2226-2237

10.1097/tp.0000000000004770 | PMID 37749812 Get It

Background. When a partial liver graft is unable to meet the demands of the recipient, a clinical phenomenon, small-for-size syndrome (SFSS), may ensue. Clear definition, diagnosis, and management are needed to optimize transplant outcomes. Methods. A Consensus Scientific committee (106 members from 21 countries) performed an extensive literature review on specific aspects of SFSS, recommendations underwent blinded review by an independent panel, and discussion/voting on the recommendations occurred at the Consensus Conference. Results. The ideal graft-to-recipient weight ratio of ≥0.8% (or graft volume standard liver volume ratio of ≥40%) is recommended. It is also recommended to measure portal pressure or portal blood flow during living donor liver transplantation and maintain a postreperfusion portal pressure of <15 mm Hg and/or portal blood flow of <250 mL/min/100 g graft weight to optimize outcomes. The typical time point to diagnose SFSS is the postoperative day 7 to facilitate treatment and intervention. An objective 3-grade stratification of severity for protocolized management of SFSS is proposed. Conclusions. The proposed grading system based on clinical and biochemical factors will help clinicians in the early identification of patients at risk of developing SFSS and institute timely therapeutic measures. The validity of this newly created grading system should be evaluated in future prospective studies.